Table 3.
Associations of SNPs associated at pā¤10ā6 in the two stage meta-analysis with secondary traits linked to breast cancer mortality in stage 1 and stage 2 combined dataset:
| Secondary trait |
rs421379 | rs3884558 | rs3785982 | rs2774307 | rs1387389 |
|---|---|---|---|---|---|
| ER-status | OR=1.13 (95% CI:0.86 to 1.47, p=0.38) |
OR=0.93 (95% CI:0.75 to 1.16, p=0.52) |
OR=1.14 (95% CI:0.94 to 1.39, p=0.54) |
OR=0.96 (95% CI:0.83 to 1.11, p=0.59) |
OR=0.97 (95% CI:0.85 to 1.10, p=0.29) |
| Nodal Status |
OR=1.55 (95%CI:0.96- 2.49, p=0.07) |
OR=1.70 (95% CI:1.14-2.55, p=0.009) |
OR=1.47 (95% CI:1.06- 2.05, p=0.02) |
OR=1.16 (95% CI:0.92-1.45, p=0.20) |
OR=1.20 (95%CI:0.98- 1.46, p=0.05) |
| M-stage | OR=1.22 (95%CI:0.88- 1.68, p=0.24) |
OR=1.42 (95% CI:1.07-1.87, p=0.01) |
OR=1.23 (95% CI:0.97- 1.56, p=0.08) |
OR=1.04 (95% CI:0.88-1.23, p=0.62) |
OR=1.07 (95%CI:0.92- 1.24, p=0.40) |
ER-status= Estrogen receptor status, M-stage=Metastasis stage